Alex Praseuth

Alex Praseuth has a diverse work experience in the biopharmaceutical industry. Alex is currently the Director of Drug Product Development and Drug Product Manufacturing at AnaptysBio, a position they have held since February 2021. Prior to that, they were an Associate Director of Drug Product Development at AnaptysBio from May 2018 to February 2021.

Before joining AnaptysBio, Alex worked at Halozyme Therapeutics, Inc. as a Senior Research Scientist from July 2015 to April 2018. Alex also had a brief role as a Senior Scientist and Team Leader at Avrio Biopharmaceuticals from February 2015 to July 2015.

Earlier in their career, Alex worked at Allergan, where they had the role of Senior Scientist from February 2011 to November 2014, and as a Scientist from May 2008 to February 2011. Alex also gained research experience as a PhD Candidate at the University of Southern California from August 2003 to May 2008.

Alex began their career as a Research Associate at Baxter BioScience from November 2000 to July 2003.

Alex Praseuth completed a Bachelor of Science degree in Pharmacological Chemistry at UC San Diego in the year 2000. Following this, they pursued a Master of Science degree in Chemical Engineering at the University of Southern California from 2001 to 2005. Continuing their education, Alex obtained a PhD in Pharmaceutical Science from the same institution, University of Southern California, from 2003 to 2008. The provided information does not specify the start year for the Bachelor's degree, only indicating that it was completed by the year 2000.